[1]
2012. Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy. Farmeconomia. Health Economics and Therapeutic Pathways. 13, 3 (Sep. 2012), 121–131. DOI:https://doi.org/10.7175/fe.v13i3.268.